Cargando...
Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects
A randomized, partial‐blind, repeat‐dose, 3‐period crossover study (NCT02027454) assessed the effect of cabotegravir on QT interval in healthy subjects. To achieve a supratherapeutic dose, each subject received cabotegravir 150 mg (30 mg × 5 tablets) every 12 hours for a total of 3 doses over 2 days...
Guardado en:
| Publicado en: | Clin Pharmacol Drug Dev |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5132079/ https://ncbi.nlm.nih.gov/pubmed/27162089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.272 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|